Benzinga··Nabaparna BhattacharyaAmneal Pharmaceuticals Surges on $1.1B Kashiv Acquisition to Dominate Biosimilars
Amneal Pharmaceuticals surged 3.76% after agreeing to acquire Kashiv BioSciences for $1.1 billion, positioning itself in the $300 billion biosimilars market.
AMRXXPHASCEacquisitionstrategic partnership